Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) announced positive results from the Phase 3 tranquility trial, which achieved its primary endpoint of being statistically superior to the vehicle for each of the two prespecified primary endpoints, Schirmer test (p=0.0001) and ≥10 mm Schirmer test responder proportions (p<0.0001)...
Canoo Inc. (NASDAQ: GOEV), an EV start-up that aspires to be a high-tech advanced mobility company, announced the signing of a definitive agreement with Walmart (NYSE: WMT) for 4,500 all-electric delivery vehicles beginning with the lifestyle delivery vehicle (LDV). The contract also has an option...
Greenwich LifeSciences, Inc. (NASDAQ: GLSI), a clinical-stage pharmaceutical company, developing immunotherapy to prevent breast cancer recurrence in patients who previously underwent surgery, announced the removal of the clinical hold on the Phase III Flamingo-01 clinical trial by the U.S Food and Drug Administration (FDA). The FDA...
The Company Digital World Acquisition Corp. (NASDAQ: DWAC) is a blank check company that seeks to forge business combinations with FinTech, Tech, or Media companies. The Company had made an initial public offer of 25,000,000 units at $10.00 per unit and made its debut on the...
Positive Results from Phase 3 trial of Sabizabulin Veru, Inc. (NASDAQ: VERU) announced the publication of results from a Phase 3 study evaluating the safety and efficacy of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome...
Iveric Bio, Inc. ( NASDAQ: ISEE) is a clinical-stage biopharmaceutical company developing transformative therapies for retinal diseases with significant unmet needs. The Company is developing a diverse portfolio of therapeutic candidates at various stages of development. The Company’s lead product candidate is Zimura (avacincaptad pegol),...
Upstart Holdings, Inc. (NASDAQ: UPST) is a cloud-based artificial intelligence lending platform that operates in the United States. The Company is a bridge between consumer demand for loans and its AI-enabled bank partners. The stock hit after an analyst downgraded it and drastically cut down...
Kezar Life Sciences, Inc. (NASDAQ: KZR), a clinical-stage biotechnology company, reported positive top-line results from the Phase 2 clinical trial named MISSION, evaluating zetomipzomib, a novel, first-in-class selective immunoproteasome inhibitor, in patients with active lupus nephritis (LN). The MISSION Phase 2 trial is an open-label study with...
Emergent BioSolutions, Inc. (NYSE: EBS), a life sciences company is developing a portfolio of vaccines and therapeutics for urgent health threats, announced the acceptance of a Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) by the U.S. Food and Drug Administration (FDA). The...
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD), a biopharmaceutical company developing small molecule drugs for treating central nervous system disorders, faced a setback at the Psychopharmacologic Drugs Advisory Committee (PDAC) meeting for pimavanserin, a drug intended to treat hallucinations and delusions associated with Alzheimer’s disease psychosis. The...
